Abbott rises after raising annual profit forecast on heart device demand
16/07/2026 12:42
BUZZ-Abbott rises after raising annual profit forecast on heart device demand ** Shares of Abbott Laboratories ABT.N up 2.43% at $91.44 premarket
** Co raises 2026 adjusted profit forecast to $5.45-$5.60/shr from prior view of $5.38-$5.58/shr, above analysts' average estimate of $5.49/shr - LSEG data
** Demand for Abbott's heart devices expected to remain strong in the second half of the year, ABT says
** Co reports Q2 adj. profit of $1.31/shr vs estimates of $1.28/shr
** Co's quarterly revenue of $12.6 billion beats expectations of $12.5 billion
** As of last close, stock down ~29% YTD
(Reporting by Sahil Pandey in Bengaluru)
Recent news on Abbott Laboratories
See all newsBrief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement